AB.PA
AB Science SA
Price:  
1.47 
EUR
Volume:  
86,259.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AB.PA EV/EBITDA

-151.6%
Upside

As of 2025-04-25, the EV/EBITDA ratio of AB Science SA (AB.PA) is -23.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AB.PA's latest enterprise value is 95.16 mil EUR. AB.PA's TTM EBITDA according to its financial statements is -3.98 mil EUR. Dividing these 2 quantities gives us the above AB.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 6.9x - 8.0x 7.6x
Forward P/E multiples 8.1x - 10.6x 9.4x
Fair Price (0.73) - (0.72) (0.76)
Upside -149.7% - -149.1% -151.6%
1.47 EUR
Stock Price
(0.76) EUR
Fair Price

AB.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-04-17 -23.40
2025-04-16 -22.82
2025-04-15 -23.11
2025-04-14 -21.72
2025-04-11 -21.95
2025-04-10 -21.52
2025-04-09 -21.37
2025-04-08 -21.37
2025-04-07 -20.79
2025-04-04 -21.02
2025-04-03 -22.30
2025-04-02 -22.21
2025-04-01 -22.39
2025-03-31 -22.01
2025-03-28 -22.24
2025-03-27 -22.53
2025-03-26 -22.18
2025-03-25 -22.62
2025-03-24 -22.50
2025-03-21 -22.68
2025-03-20 -22.79
2025-03-19 -22.68
2025-03-18 -22.36
2025-03-17 -22.13
2025-03-14 -22.24
2025-03-13 -22.30
2025-03-12 -22.74
2025-03-11 -22.56
2025-03-10 -23.00
2025-03-07 -22.65
2025-03-06 -23.55
2025-03-05 -21.95
2025-03-04 -21.81
2025-03-03 -22.47
2025-02-28 -22.33
2025-02-27 -23.05
2025-02-26 -21.98
2025-02-25 -21.83
2025-02-24 -22.24
2025-02-21 -21.83
2025-02-20 -22.10
2025-02-19 -22.30
2025-02-18 -23.32
2025-02-17 -24.42
2025-02-14 -24.56
2025-02-13 -24.86
2025-02-12 -25.41
2025-02-11 -24.94
2025-02-10 -25.20
2025-02-07 -25.52